Form 4: OmniAb Chief Legal Officer Boosts Equity Holdings

OmniAb's Chief Legal Officer, Charles S. Berkman, reported significant equity transactions including RSU vesting, tax-related share sales, and new grants of RSUs and stock options.

Summary

• Charles S. Berkman, Chief Legal Officer of OmniAb, Inc. (OABI), reported transactions on February 18, 2026.
• 18,750 shares of Common Stock were acquired upon the vesting of Restricted Stock Units (RSUs) at an exercise price of $0.
• 9,673 shares of Common Stock were disposed of at a weighted average price of $1.71 (ranging from $1.68 to $1.73) to cover tax withholding obligations related to RSU vesting.
• A new grant of 60,000 Restricted Stock Units (RSUs) was acquired, with each RSU representing a contingent right to receive one share of Common Stock at an exercise price of $0.
• A new grant of 600,000 Stock Options was acquired with an exercise price of $1.71.
• Following these transactions, Charles S. Berkman beneficially owns 392,700 shares of Common Stock, 124,584 Restricted Stock Units, and 600,000 Stock Options.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a moderately positive development, reflecting ongoing executive compensation and increased alignment through new equity grants, despite a routine tax-related share sale.

Positives

• The reporting person received a new grant of 60,000 Restricted Stock Units, increasing potential future equity ownership.
• A new grant of 600,000 Stock Options was awarded, further aligning the executive's interests with shareholder value creation.
• The vesting of 18,750 RSUs converted into common stock, increasing direct share ownership.

Negatives

• 9,673 shares of Common Stock were sold to cover tax withholding obligations, reducing direct share ownership, although this was a non-discretionary transaction.

Future Outlook

The reporting person's future equity ownership is set to increase through the vesting of 124,584 Restricted Stock Units, with vesting schedules beginning in February 2026 and February 2027, and the vesting and exercisability of 600,000 Stock Options over a period starting six months after the grant date and continuing in monthly installments thereafter until February 2036.

Management Comments

• The sale of 9,673 shares was mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a 'sell-to-cover' transaction and does not represent discretionary trades by the reporting person.

Industry Context

StockSavvy.ai notes that the granting of Restricted Stock Units and Stock Options is a standard practice in executive compensation across various industries. These equity-based incentives are designed to align the interests of executives with those of shareholders by tying a portion of their compensation to the company's long-term performance and stock price appreciation.

Comparison to Industry Standards

• StockSavvy.ai notes that Form 4 filings report individual insider transactions and do not typically provide data for direct comparison to industry-wide company performance benchmarks or specific project results. The reported transactions are part of an individual executive's compensation structure.

Stakeholder Impact

• Shareholders may benefit from increased alignment of the Chief Legal Officer's financial interests with the company's long-term performance due to significant new equity grants.

Next Steps

• The 18,750 RSUs will continue to vest in three substantially equal annual installments beginning on February 18, 2026.
• The 60,000 RSUs will vest in three substantially equal annual installments beginning on February 18, 2027.
• The 600,000 Stock Options will vest and become exercisable as to 12.5% of the underlying shares 6 months after the grant date, and in 42 substantially equal monthly installments thereafter.

Key Dates

Keywords

OmniAb, OABI, Form 4, Insider Transaction, Executive Compensation, Restricted Stock Units, Stock Options, Equity Grant, Chief Legal Officer